Related Experiment Videos
Ibrutinib and Rituximab in Waldenström's Macroglobulinemia
Adam J Olszewski1, Jorge J Castillo2
1Warren Alpert Medical School of Brown University, Providence, RI adam_olszewski@brown.edu
The New England Journal of Medicine
|November 16, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.
American journal of hematology·2026
Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
The New England journal of medicine·2026
Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
The New England journal of medicine·2026
Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
The New England journal of medicine·2026
Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain.
The New England journal of medicine·2026
Complete Revascularization Guided by Functional Coronary Angiography in STEMI.
The New England journal of medicine·2026
Immediate Ambulatory Electrocardiographic Monitoring in Syncope.
The New England journal of medicine·2026
Improving diagnostic strategies for plasma cell dyscrasias: a laboratory perspective on Bence Jones proteinuria.
Clinica chimica acta; international journal of clinical chemistry·2026
Direct immunofluorescence in the clinic for pemphigus and pemphigoid disorders.
Expert review of clinical immunology·2026